John M. Janusz

664 total citations
25 papers, 504 citations indexed

About

John M. Janusz is a scholar working on Organic Chemistry, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, John M. Janusz has authored 25 papers receiving a total of 504 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Organic Chemistry, 11 papers in Molecular Biology and 6 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in John M. Janusz's work include Cardiac electrophysiology and arrhythmias (6 papers), Atrial Fibrillation Management and Outcomes (5 papers) and Cardiac Arrhythmias and Treatments (4 papers). John M. Janusz is often cited by papers focused on Cardiac electrophysiology and arrhythmias (6 papers), Atrial Fibrillation Management and Outcomes (5 papers) and Cardiac Arrhythmias and Treatments (4 papers). John M. Janusz collaborates with scholars based in United States, India and Canada. John M. Janusz's co-authors include Shengde Wu, Jerome A. Berson, Michael Murawsky, Benjamin E. Blass, Gina M. Fadayel, Thomas C. Bruice, Bin Fang, C. M. Jackson, Richard M. Hedges and Gary A. Kerckaert and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Medicinal Chemistry and Tetrahedron Letters.

In The Last Decade

John M. Janusz

25 papers receiving 475 citations

Peers

John M. Janusz
Graham N. Maw United Kingdom
Carl D. Davis United States
David J. Rawson United Kingdom
Andrew M. Griffin United States
Piyasena Hewawasam United States
Graham N. Maw United Kingdom
John M. Janusz
Citations per year, relative to John M. Janusz John M. Janusz (= 1×) peers Graham N. Maw

Countries citing papers authored by John M. Janusz

Since Specialization
Citations

This map shows the geographic impact of John M. Janusz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John M. Janusz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John M. Janusz more than expected).

Fields of papers citing papers by John M. Janusz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John M. Janusz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John M. Janusz. The network helps show where John M. Janusz may publish in the future.

Co-authorship network of co-authors of John M. Janusz

This figure shows the co-authorship network connecting the top 25 collaborators of John M. Janusz. A scholar is included among the top collaborators of John M. Janusz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John M. Janusz. John M. Janusz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Blass, Benjamin E., Andrew Fensome, Eugene J. Trybulski, et al.. (2009). Selective Kv1.5 Blockers: Development of (R)-1-(Methylsulfonylamino)-3-[2-(4-methoxyphenyl)ethyl]-4-(4-methoxyphenyl)-2-imidazolidinone (KVI-020/WYE-160020) as a Potential Treatment for Atrial Arrhythmia. Journal of Medicinal Chemistry. 52(21). 6531–6534. 16 indexed citations
4.
Wu, Shengde, et al.. (2006). Discovery and synthesis of tetrahydroindolone-derived carbamates as Kv1.5 blockers. Bioorganic & Medicinal Chemistry Letters. 16(22). 5855–5858. 19 indexed citations
5.
Jackson, C. M., Benjamin E. Blass, Gina M. Fadayel, et al.. (2006). Evolution of thiazolidine-based blockers of human Kv1.5 for the treatment of atrial arrhythmias. Bioorganic & Medicinal Chemistry Letters. 17(1). 282–284. 32 indexed citations
6.
Wu, Shengde, John M. Janusz, Benjamin E. Blass, et al.. (2006). Discovery and synthesis of tetrahydroindolone derived semicarbazones as selective Kv1.5 blockers. Bioorganic & Medicinal Chemistry Letters. 16(22). 5859–5863. 31 indexed citations
7.
Wu, Shengde, John M. Janusz, Benjamin E. Blass, et al.. (2006). Discovery and in vitro/in vivo studies of tetrazole derivatives as Kv1.5 blockers. Bioorganic & Medicinal Chemistry Letters. 16(24). 6213–6218. 49 indexed citations
8.
Blass, Benjamin E., Wenlin Lee, Neil T. Fairweather, et al.. (2006). Synthesis and evaluation of (2-phenethyl-2H-1,2,3-triazol-4-yl)(phenyl)methanones as Kv1.5 channel blockers for the treatment of atrial fibrillation. Bioorganic & Medicinal Chemistry Letters. 16(17). 4629–4632. 27 indexed citations
9.
Wu, Shengde & John M. Janusz. (2000). Solid-phase synthesis of 3-aminohydantoin, dihydrouracil, thiohydantoin and dihydrothiouracil derivatives. Tetrahedron Letters. 41(8). 1165–1169. 16 indexed citations
10.
Wu, Shengde, et al.. (2000). An efficient one-pot synthesis of 3-aminohydantoin and 3-aminodihydrouracil derivatives. Tetrahedron Letters. 41(8). 1159–1163. 7 indexed citations
11.
Janusz, John M., Patricia A. Young, Michael W. Scherz, et al.. (1998). New Cyclooxygenase-2/5-Lipoxygenase Inhibitors. 2. 7-tert-Butyl-2,3-dihydro-3,3-dimethylbenzofuran Derivatives as Gastrointestinal Safe Antiinflammatory and Analgesic Agents:  Variations of the Dihydrobenzofuran Ring. Journal of Medicinal Chemistry. 41(7). 1124–1137. 30 indexed citations
13.
Janusz, John M., Patricia A. Young, Michael W. Scherz, et al.. (1998). New Cyclooxygenase-2/5-Lipoxygenase Inhibitors. 2. 7-tert-Butyl-2,3-dihydro-3,3-dimethylbenzofuran Derivatives as Gastrointestinal Safe Antiinflammatory and Analgesic Agents:  Variations of the Dihydrobenzofuran Ring. Journal of Medicinal Chemistry. 41(16). 3102–3102. 3 indexed citations
14.
Janusz, John M., et al.. (1993). Vanilloids. 1. Analogs of capsaicin with antinociceptive and antiinflammatory activity. Journal of Medicinal Chemistry. 36(18). 2595–2604. 65 indexed citations
15.
Janusz, John M., et al.. (1990). High potency dipeptide sweeteners. 1. L-Aspartyl-D-phenylglycine esters. Journal of Medicinal Chemistry. 33(3). 1052–1061. 21 indexed citations
16.
Janusz, John M., et al.. (1990). High-potency dipeptide sweeteners. 2. L-Aspartylfuryl-, thienyl-, and imidazolylglycine esters. Journal of Medicinal Chemistry. 33(6). 1676–1682. 6 indexed citations
17.
Janusz, John M., et al.. (1979). Solution chemistry of the syn- and anti-tetrahydrodiol epoxides, the syn- and anti-tetrahydrodimethoxy epoxides, and the 1,2- and 1,4-tetrahydro epoxides of naphthalene. Journal of the American Chemical Society. 101(19). 5679–5687. 19 indexed citations
18.
Janusz, John M. & Jerome A. Berson. (1978). Trisection of reaction pathways in automerization of 6-methylenebicyclo[3.2.1]oct-2-ene. Journal of the American Chemical Society. 100(7). 2237–2239. 11 indexed citations
19.
Janusz, John M., et al.. (1978). The importance of intramolecular hydrogen bonding on the reactivity of tetrahydro diol epoxides. Journal of the American Chemical Society. 100(26). 8269–8271. 8 indexed citations
20.
Janusz, John M., et al.. (1977). A thermal[1,3]sigmatropic acyl shift in the degenerate rearrangement of bicyclo[3.2.1]oct-2-en-7-one. Journal of the American Chemical Society. 99(26). 8509–8510. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026